Primum non nocere: An evolutionary analysis of whether antidepressants do more harm than good

Frontiers in Psychology

Volumn 3, Issue APR, 2012, Pages

  Andrews, Paul W ^a,b   Thomson, J Anderson ^c   Amstadter, Ananda ^b   Neale, Michael C ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antidepressant medications; Depression; Mortality; Placebo; Rebound; Risks; Safety; Side effects

Indexed keywords

EID: 84867128062     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2012.00117     Document Type: Review

References (201)

1. Adell, A., Castro, E., Celeda, P., Bortolozzi, A., Pazos, A., and Artigas, F. (2005). Strategies for productring faster acting antidepressants. Drug Discov. Today 10, 578-585.
2. Almeida, O. P., Alfonso, H., Hankey, G. J., and Flicker, L. (2010). Depression, antidepressant use and mortality in later life: the health in men study. PLoS ONE 5, e11266. doi:10.1371/journal.pone.0011266.
3. Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., and Maier, S. F. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8, 365-371.
4. Amat, J., Paul, E., Zarza, C., Watkins, L. R., and Maier, S. F. (2006). Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. J. Neurosci. 26, 13264-13272.
5. American Psychiatric Association (APA). (2000a). Handbook of Psy-chiatric Measures. Washington, DC: American Psychiatric Association.
6. American Psychiatric Association (APA). (2000b). (DSM-IV-TR) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn, Text Revision Edn. Washington, DC: American Psychiatric Press, Inc.
7. Andrews, P. W., Aggen, S. H., Miller, G. F., Radi, C., Dencoff, J. E., and Neale, M. C. (2007). The functional design of depression's influence on attention: a preliminary test of alternative controlprocess mechanisms. Evol. Psychol. 5, 584-604.
8. Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., and Neale, M. C. (2011). Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front. Psychol. 2:159. doi:10.3389/fpsyg.2011.00159.
9. Andrews, P. W., and Thomson, J. A. Jr. (2009). The bright side of being blue: depression as an adaptation for analyzing complex problems. Psychol. Rev. 116, 620-654.
10. Angell, M. (2011). The Epidemic of Men-tal Illness: Why? New York: The New York Review of Books.
11. Angst, J., Delinistula, A., Stabl, M., and Stassen, H. H. (1993). Is a cutoff score a suitable measure of treatment outcome in short-term trials in depression? A methodological metaanalysis. Hum. Psychopharmacol. 8, 311-317.
12. Appenheimer, M. M., Chen, Q., Girard, R. A., Wang, W. C., and Evans, S. S. (2005). Impact of feverrange thermal stress on lymphocyteendothelial adhesion and lymphocyte trafficking. Immunol. Invest. 34, 295-323.
13. Azmitia, E. C. (2001). Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56, 413-424.
14. Azmitia, E. C. (2007). Serotonin and brain: evolution, neuroplasticity, and homeostasis. Int. Rev. Neurobiol. 77, 31-56.
15. Azmitia, E. C. (2010). "Evolution of serotonin: sunlight to suicide," in Handbook of the Behavioral Neurobiology of Serotonin, eds C. P. Muller and B. L. Jacobs (Burlington, MA: Academic Press), 3-22.
16. Bagby, R. M., Ryder, A. G., Schuller, D. R., and Marshall, M. B. (2004). The Hamilton depression rating scale: has the gold standard become a lead weight? Am. J. Psychiatry 161, 2163-2177.
17. Bakkaloglu, B., Yabanoglu, S., Ozyuksel, B. R., Uaar, G., Ertugrul, A., and Demir, B., Uluǧ, B. (2008). Platelet and plasma serotonin levels and platelet monoamine oxidase activity in patients with major depression: effects of sertraline treatment. Turk. J. Biochem. 33, 97-103.
18. Baldessarini, R. J., Tondo, L., Strombom, I. M., Dominguez, S., Fawcett, J., Licinio, J., Oquendo, M. A., Tollefson, G. D., Valuck, R. J., and Tohen, M. (2007). Ecological studies of antidepressant treatment and suicidal risks. Harv. Rev. Psychiatry 15, 133-145.
19. Bar-Oz, B., Einarson, T., Einarson, A., Boskovic, R., O'Brien, L., Malm, H., Bérard, A., and Koren, G. (2007). Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin. Ther. 29, 918-926.
20. Bartholoma, P., Erlandsson, N., Kaufmann, K., Rossler, O. G., Baumann, B., Wirth, T., Giehl, K. M., and Thiel, G. (2002). Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. Biochem. Pharmacol. 63, 1507-1516.
21. Berger, M., Gray, J. A., and Roth, B. L. (2009). The expanded biology of serotonin. Annu.Rev.Med.60, 355-366.
22. Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., and Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., Higgins, S. B., and Swindell, B. B. (1997). The effects of ibuprofen on the physiology and survival of patients with sepsis. N. Engl.J.Med.336, 912-918.
23. Best, J., Nijhout, H. F., and Reed, M. (2010). Serotonin synthesis, release and reuptake in terminals: a mathematical model. Theor. Biol. Med. Model. 7. doi: 10.1186/1742-4682-7-34.
24. Blatteis, C. M. (2003). Fever: pathological or physiological, injurious or beneficial? J. Therm. Biol. 28, 1-13.
25. Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., and Schene, A. H. (2008). Continuation and maintenance use of antidepressants in recurrent depression. Psychother. Psychosom. 77, 17-26.
26. Bonin, R. (2012). "Treating depression: is there a placebo effect?" in 60 Min-utes (New York, NY: CBS Broadcasting, Inc.).
27. Brambilla, P., Cipriani, A., Hotopf, M., and Barbui, C. (2005). Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychia-try 38, 69-77.
28. Brandts, C. H., Ndjave, M., Graninger, W., and Kremsner, P. G. (1997). Effect of paracetamol on parasite clearance time in Plasmod-ium falciparum malaria. Lancet 350, 704-709.
29. Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., and Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., Konstam, M. A., Baron, J. A., and Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. (2005). Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N.Engl.J.Med.352, 1092-1102.
30. Bryant, R. E., Hood, A. F., Hood, C. E., and Koenig, M. G. (1971). Factors affecting mortality of gram-negative rod bacteremia. Arch. Intern. Med. 127, 120-128.
31. Bull, S. A., Hunkeler, E. M., Lee, J. Y., Rowland, C. R., Williamson, T. E., Schwab, J. R., and Hurt, S. W. (2002). Discontinuing or switching selective serotonin-reuptake inhibitors. Ann. Pharmacother. 36, 578-584.
32. Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., Wong, D. T., and Perry, K. W. (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacol-ogy (Berl.) 160, 353-361.
33. Byrne, S. E., and Rothschild, A. J. (1998). Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J. Clin. Psychiatry 59, 279-288.
34. Carter, O. L., Burr, D. C., Pettigrew, J. D., Wallis, G. M., Hasler, F., and Vollenweider, F. X. (2005). Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. J. Cogn. Neurosci. 17, 1497-1508.
35. Chen, L., Hamaguchi, K., Ogawa, M., Hamada, S., and Okado, N. (1994). PCPA reduces both monoaminergic afferents and non-monoaminergic synapses in the cerebral cortex. Neu-rosci. Res. 19, 111-115.
36. Cheng, H. C., Ulane, C. M., and Burke, R. E. (2010). Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 67, 715-725.
37. Chollet, F., Tardy, J., Albucher, J. F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., and Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 10, 123-130.
38. Cloonan, S. M., and Williams, D. C. (2011). The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma. Int. J. Cancer 128, 1712-1723.
39. Cohen, H. W., Gibson, G., and Alderman, M. H. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am.J.Med.108, 2-8.
40. Cohen, Z., Bonvento, G., Lacombe, P., and Hamel, E. (1996). Serotonin in the regulation of brain microcirculation. Prog. Neurobiol. 50, 335.
41. Cohn, J. B., and Wilcox, C. S. (1992). Paroxetine in major depression -a double-blind trial with imipramine and placebo. J. Clin. Psychiatry 53, 52-56.
42. Cole, J. A., Ephross, S. A., Cosmatos, I. S., and Walker, A. M. (2007). Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol. Drug Saf. 16, 1075-1085.
43. Cosgrove, L., Shi, L., Creasey, D. E., naya-McKivergan, M., Myers, J. A., and Huybrechts, K. F. (2011). Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS ONE 6, e18210. doi:10.1371/journal.pone.0018210.
44. Cotran, R. S., Kumar, V., Collins, T., and Robbins, S. (1998). Robbins' Patho-logic Basis of Disease.London:W.B. Saunders.
45. Coupland, C., Dhiman, D., Morriss, R., Arthur, A., Barton, G., and Hippisley-Cox, J. (2011). Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 343. doi: 10.1136/bmj.d4551.
46. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., and Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch.Gen.Psy-chiatry 68, 1104-1112.
47. Cryan, J. F., O'Leary, O. F., Jin, S. H., Friedland, J. C., Ouyang, M., Hirsch, B. R., Page, M. E., Dalvi, A., Thomas, S. A., and Lucki, I. (2004). Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc. Natl. Acad. Sci. U.S.A. 101, 8186-8191.
48. Cumming, R. G. (1998). Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 12, 43-53.
49. Dall, M., De Muckadell, O. B. S., Lassen, A. T., Hansen, J. M., and Hallas, J. (2009). An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin. Gas-troenterol. Hepatol. 7, 1314-1321.
50. Demyttenaere, K., Enzlin, P., Dewe, W., Boulanger, B., De Bie, J., De Troyer, W., and Mesters, P. (2001). Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J. Clin. Psychiatry 62, 30-33.
51. Dong, H. X., Csernansky, C. A., Goico, B., and Csernansky, J. G. (2003). Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 23, 1742-1749.
52. Doran, T. F., Deangelis, C., Baumgardner, R. A., and Mellits, E. D. (1989). Acetaminophen: more harm than good for chickenpox. J. Pediatr. 114, 1045-1048.
53. Duman, R. S. (2004). Depression: a case of neuronal life and death? Biol. Psychiatry 56, 140-145.
54. Elgot, A., Ahboucha, S., Bouyatas, M. M., Fevre-Montange, M., and Gamrani, H. (2009). Water deprivation affects serotoninergic system and glycoprotein secretion in the sub-commissural organ of a desert rodent Meriones shawi. Neurosci. Lett. 466, 6-10.
55. Ellfolk, M., and Malm, H. (2010). Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod. Toxicol. 30, 249-260.
56. El-Mallakh, R. S., Gao, Y. L., and Roberts, R. J. (2011). Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression. Med. Hypotheses 76, 769-773.
57. Encinas, J. M., Vaahtokari, A., and Enikolopov, G. (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc. Natl. Acad. Sci. U.S.A. 103, 8233-8238.
58. Fava, G. A., and Offidani, E. (2011). The mechanisms of tolerance in antidepressant action. Prog. Neuropsy-chopharmacol. Biol. Psychiatry 35, 1593-1602.
59. Felton, T. M., Kang, T. B., Hjorth, S., and Auerbach, S. B. (2003). Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch. Pharmacol. 367, 297-305.
60. Fergusson, D., Doucette, S., Cranley, K., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., and Hutton, B. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330, 396-399.
61. Fisher, H. E., and Thomson, J. A. (2006). "Lust, romance, attachment: do the side effects of serotonin-enhancing antidepressants jeopardize romantic love, marriage, and fertility?" in Evo-lutionary Cognitive Neuroscience, eds S. M. Platek, J. P. Keenan, and T. K. Shackelford (Cambridge, MA: The MIT Press), 245-283.
62. Flock, A., Zobel, A., Bauriedel, G., Tuleta, I., Hammerstingl, C., Hofels, S., Schuhmacher, A., Maier, W., Nickenig, G., and Skowasch, D. (2010). Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thromb. Res. 126, E83-E87.
63. Fonseca, F. V., Mecawi, A. S., Araujo, I. G., meida-Pereira, G., magalhaes-Nunes, A. P., Badaue-Passos, D. Jr., and Reis, L. C. (2009). Role of the 5-HT(1A) somatodendritic autoreceptor in the dorsal raphe nucleus on salt satiety signaling in rats. Exp. Neurol. 217, 353-360.
64. Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., and Fawcett, J. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303, 47-53.
65. Ganzel, B. L., Morris, P.A., andWethington, E. (2010). Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol. Rev. 117, 134-174.
66. Gawaz, M., Langer, H., and May, A. E. (2005). Platelets in inflammation and atherogenesis. J. Clin. Invest. 115, 3378-3384.
67. Gershon, M. D. (2004). Serotonin receptors and transporters: roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 20, 3-14.
68. Gershon, M. D., and Tack, J. (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414.
69. Ghaemi, S. N., and Thommi, S. B. (2010). Death by confounding: bias and mortality. Int. J. Clin. Pract. 64, 1009-1014.
70. Gibson, J. E., Hubbard, R. B., Smith, C. J. P., Tata, L. J., Britton, J. R., and Fogarty, A. W. (2009). Use of selfcontrolled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am. J. Epidemiol. 169, 761-768.
71. Goveas, J. S., Espeland, M. A., Woods, N. F., Wassertheil-Smoller, S., and Kotchen, J. M. (2011). Depressive symptoms and incidence of mild cognitive impairment and probable eementia in elderly women: the women's health initiative memory study. J. Am. Geriatr. Soc. 59, 57-66.
72. Graf, M. C., Gaudiano, B. A., and Geller, P. A. (2008). Written emotional disclosure: a controlled study of the benefits of expressive writing homework in outpatient psychotherapy. Psychother. Res. 18, 389-399.
73. Graham, N. M. H., Burrell, C. J., Douglas, R. M., Debelle, P., and Davies, L. (1990). Adverse-effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirusinfected volunteers. J. Infect. Dis. 162, 1277-1282.
74. Hagen, E. H. (2003). "The bargaining model of depression," in Genetic and Cultural Evolution of Cooper-ation, ed. P. Hammerstein (Cambridge, MA: MIT Press), 95-123.
75. Hamilton, M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 23, 56-62.
76. Hanson, N. D., Owens, M. J., and Nemeroff, C. B. (2011). Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsy-chopharmacology 36, 2589-2602.
77. Hasday, J. D., Fairchild, K. D., and Shanholtz, C. (2000). The role of fever in the infected host. Microbes Infect. 2, 1891-1904.
78. Hata, M., Yagi, Y., Sezai, A., Yoshitake, I., Wakui, S., Takasaka, A., Kawachi, H., Murakami, T., Minami, K., and Shiono, M. (2011). Efficacy of prophylactic treatment with selective serotonin reuptake inhibitors for depression after open-heart surgery. Surg. Today 41, 791-794.
79. Hayes, A. M., Beevers, C. G., Feldman, G. C., Laurenceau, J. P., and Perlman, C. (2005). Avoidance and processing as predictors of symptom change and positive growth in an integrative therapy for depression. Int. J. Behav. Med. 12, 111-122.
80. Hayes, A. M., Feldman, G. C., Beevers, C. G., Laurenceau, J. P., Cardaciotto, L., and Lewis-Smith, J. (2007). Discontinuities and cognitive changes in an exposure-based cognitive therapy for depression. J. Consult. Clin. Psychol. 75, 409-421.
81. Heger, C. D., and Collins, R. N. (2004). Platelet activation and "crossover appeal": Rab and Rho families united by common links to serotonin. Mol. Interv. 4, 79-81.
82. Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., and Tecott, L. H. (1998). Elevated anxiety and antidepressantlike responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U.S.A. 95, 15049-15054.
83. Hendrick, V., Gitlin, M., Altshuler, L., and Korenman, S. (2000). Antidepressant medications, mood and male fertility. Psychoneuroen-docrinology 25, 37-51.
84. Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
85. Hernandez-Cueto, C., Girela, E., and Sweet, D. J. (2000). Advances in the diagnosis of wound vitality -a review. Am. J. Forensic Med. Pathol. 21, 21-31.
86. Herrup, K., Neve, R., Ackerman, S. L., and Copani, A. (2004). Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 24, 9232-9239.
87. Hindmarch, I. (2009). Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder. Int. J. Clin. Pract. 63, 1085-1094.
88. Hochochka, P. W., and Somero, G. N. (2002). Biochemical Adaptation: Mechanism and Process in Physiolog-ical Evolution. New York, NY: Oxford University Press.
89. Holt, A., and Baker, G. B. (1996). Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn Schmiedebergs Arch. Pharmacol. 354, 17-24.
90. Holtzer, R., Friedman, R., Lipton, R. B., Katz, M., Xue, X., and Verghese, J. (2007). The relationship between specific cognitive functions and falls in aging. Neuropsychology 21, 540-548.
91. Homberg, J. R., Schubert, D., and Gaspar, P. (2010). New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 31, 60-65.
92. Honig, G., Jongsma, M. E., van der Hart, M. C. G., and Tecott, L. H. (2009). Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain. PLoS ONE 4, e6797. doi:10.1371/journal.pone.0006797.
93. Horwitz, A. V., and Wakefield, J. C. (2007). The Loss of Sadness: How Psy-chiatry Transformed Normal Sorrow into Depressive Disorder.NewYork, NY: Oxford University Press.
94. Hranilovic, D., Blazevic, S., Ivica, N., Cicin-Sain, L., and Oreskovic, D. (2011). The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats. Neurochem. Int. 59, 202-207.
95. Hyman, S. E., and Nestler, E. J. (1996). Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychi-atry 153, 151-162.
96. Insel, T. R., and Wang, P. S. (2009). The STAR*D trial: revealing the need for better treatments. Psychiatr. Serv. 60, 1466-1467.
97. Jackson, G. E. (2008). Chemo brain -a psychotropic drug phenomenon? Med. Hypotheses 70, 572-577.
98. Jackson, G. E. (2009). Drug-Induced Dementia: A Perfect Crime. Bloomington, IN: AuthorHouse.
99. Jacob, S., and Spinler, S. A. (2006). Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann. Pharmacother. 40, 1618-1622.
100. Jacobs, B. L., and Fornal, C. A. (1995). Activation of 5-HT neuronal activity during motor behavior. Semin. Neurosci. 7, 401-408.
101. Jacobs, B. L., and Fornal, C. A. (1999). Activity of serotonergic neurons in behaving animals. Neuropsychophar-macology 21, S9-S15.
102. Jimenez-Trejo, F., Tapia-Rodriguez, M., Queiroz, D. B. C., Padilla, P., Avellar, M. C.W., Manzano, P. R., Manjarrez-Gutiérrez, G., and Gutiérrez-Ospina, G. (2007). Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation and variations associated with adult mating status: morphological and biochemical studies. J. Androl. 28, 136-149.
103. Johnson, A. K., and Thunhorst, R. L. (1997). The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front. Neuroendocrinol. 18:292-353. doi:10.1006/frne.1997.0153.
104. Jorge, R. E., Robinson, R. G., and Ardnt, S. (2004). Drs. Jorge and Robinson reply. Am. J. Psychiatry 161, 1507-1508.
105. Jorge, R. E., Robinson, R. G., Arndt, S., and Starkstein, S. (2003). Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am. J. Psychiatry 160, 1823-1829.
106. Kalia, M., O'Callaghan, J. P., Miller, D. B., and Kramer, M. (2000). Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry. Brain Res. 858, 92-105.
107. Kearns, N. P., Cruickshank, C. A., Mcguigan, K. J., Riley, S. A., Shaw, S. P., and Snaith, R. P. (1982). A comparison of depression rating scales. Br. J. Psychiatry 141, 45-49.
108. Kelly, O., Matheson, K., Ravindran, A., Merali, Z., and Anisman, H. (2007). Ruminative-coping among patients with dysthymia before and after pharmacotherapy. Depress. Anxiety 24, 233-243.
109. Kessler, R. C., Merikangas, K. R., and Wang, P. S. (2007). Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twentyfirst century. Annu. Rev. Clin. Psy-chol. 3, 137-158.
110. Keszthelyi, D., Troost, F. J., and Masclee, A. A. M. (2009). Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol. Motil. 21, 1239-1249.
111. Khan, A., Bhat, A., Faucett, J., Kolts, R., and Brown, W. A. (2011). Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity. Psychopharmacology (Berl.) 214, 961-965.
112. Khan, A., Brodhead, A. E., Kolts, R. L., and Brown, W. A. (2005). Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J. Psychiatr. Res. 39, 145-150.
113. Khan, A., Leventhal, R. M., Khan, S. R., and Brown, W. A. (2002). Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J. Clin. Psychopharmacol. 22, 40-45.
114. Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., and Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PloS Med. 5, e45. doi:10.1371/journal.pmed.0050045.
115. Kluger, M. J., Kozak, W., Conn, C. A., Leon, L. R., and Soszynski, D. (1997). "The adaptive value of fever," in Fever: Basic Mechanisms and Man-agement, 2nd Edn, ed. P. A. Mackowiak (Philadelphia, PA: Lippincott-Raven), 255-266.
116. Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T., and Suzuki, H. (2010). Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc. Natl. Acad. Sci. U.S.A. 107, 8434-8439.
117. Kovacevic, T., Skelin, I., and Diksic, M. (2010). Chronic fluoxetine treatment has a larger effect on the density of a serotonin transporter in the Flinders Sensitive Line (FSL) rat model of depression than in normal rats. Synapse 64, 231-240.
118. Kramer, P. D. (2005). Against Depres-sion. New York, NY: Viking.
119. Kramer, P. D. (2011). In defense of antidepressants. The NewYork Times, 9th July.
120. Lehrer, J. (2010). Depression's upside. The New York Times Sunday Maga-zine, 28th Feb.
121. Lesurtel, M., Soll, C., Graf, R., and Clavien, P. A. (2008). Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives. Cell.Mol.LifeSci.65, 940-952.
122. Levkovitz, Y., Gil-Ad, I., Zeldich, E., Dayag, M., and Weizman, A. (2005). Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines -evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J. Mol. Neurosci. 27, 29-42.
123. Linder, A. E., Ni, W., Diaz, J. L., Szasz, T., Burnett, R., and Watts, S. W. (2007). Serotonin (5-HT) in veins: not all in vain. J. Pharmacol. Exp. Ther. 323, 415-421.
124. Mackowiak, P. A., Browne, R. H., Southern, P. M., and Smith, J. W. (1980). Polymicrobial sepsis: an analysis of 184 cases using log-linear models. Am.J.Med.Sci.280, 73-80.
125. Matondo, R. B., Punt, C., Homberg, J., Toussaint, M. J. M., Kisjes, R., Korporaal, S. J., Akkerman, J. W., Cuppen, E., and de Bruin, A. (2009). Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G963-G968.
126. Mayorga, A. J., Dalvi, A., Page, M. E., Zimov-Levinson, S., Hen, R., and Lucki, I. (2001). Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant. J. Pharmacol. Exp. Ther. 298, 1101-1107.
127. McEwen, B. S. (2000). The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886, 172-189.
128. McGrath, P. J., Stewart, J. W., Quitkin, F. M., Ying, C., Alpert, J. E., and Nierenberg, A. A., Fava, M., Cheng, J., and Petkova, E. (2006). Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am. J. Psychiatry 163, 1542-1548.
129. Meier, C. R., Schlienger, R. G., and Jick, H. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br. J. Clin. Pharmacol. 52, 179-184.
130. Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., and Egberts, A. C. G. (2004). Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch. Intern. Med. 164, 2367-2370.
131. Mercado, C. P., and Kilic, F. (2010). Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol. Interv. 10, 231-241.
132. Monster, T. B. M., Johnsen, S. P., Olsen, M. L., McLaughlin, J. K., and Sorensen, H. T. (2004). Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am.J.Med.117, 732-737.
133. Moret, C., Isaac, M., and Briley, M. (2009). Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J. Psy-chopharmacol. 23, 967-974.
134. Morrow, J., and Nolen-Hoeksema, S. (1990). Effects of responses to depression on the remediation of depressive affect. J. Pers. Soc. Psychol. 58, 519-527.
135. Musselman, D. L., Marzec, U. M., Manatunga, A., Penna, S., Reemsnyder, A., Knight, B. T., Baron, A., Hanson, S. R., and Nemeroff, C.B. (2000). Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch. Gen. Psychiatry 57, 875-882.
136. Mutlu, O., Ulak, G., Celikyurt, I. K., Akar, F. Y., and Erden, F. (2011). Effects of citalopram on cognitive performance in passive avoidance, elevated plus maze and three-panel runway tasks in naive rats. Chin. J. Physiol. 54, 36-46.
137. National Institute for Clinical Excellence. (2004). Depression: Manage-ment of Depression in Primary and Secondary Care. London: National Institute for Clinical Excellence.
138. Nesse, R. M., andWilliams, G. C. (1994). Why We Get Sick: The New Science of Darwinian Medicine.NewYork, NY: Times Books.
139. Nolen-Hoeksema, S., and Morrow, J. (1993). Effects of rumination and distraction on naturally-occurring depressed mood. Cogn. Emot. 7, 561-570.
140. Nordlind, K., Azmitia, E. C., and Slominski, A. (2008). The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp. Der-matol. 17, 301-311.
141. O'Hanlon, J. F., Robbe, H. W. J., Vermeeren, A., Van Leeuwen, C., and Danjou, P. E. (1998). Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J. Clin. Psychopharmacol. 18, 212-221.
142. Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., and Pincus, H. A. (2002). National trends in the outpatient treatment of depression. JAMA 287, 203-209.
143. Paciaroni, M., Agnelli, G., Micheli, S., and Caso, V. (2007). Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke-ametaanalysis of randomized controlled trials. Stroke 38, 423-430.
144. Park, R. J., Goodyer, I. M., and Teasdale, J. D. (2004). Effects of induced rumination and distraction on mood and overgeneral autobiographical memory in adolescent major depressive disorder and controls. J. Child Psy-chol. Psychiatry 45, 996-1006.
145. Paulmann, N., Grohmann, M., Voigt, J. P., Bert, B., Vowinckel, J., Bader, M., Skelin, M., Jevsek, M., Fink, H., Rupnik, M., and Walther, D. J. (2009). Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 7, e1000229. doi:10.1371/journal.pbio.1000229.
146. Perera, T. D., Dwork, A. J., Keegan, K. A., Thirumangalakudi, L., Lipira, C. M., Joyce, N., Lange, C., Higley, J. D., Rosoklija, G., Hen, R., Sackeim, H. A., and Coplan, J. D. (2011). Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS ONE 6, e17600. doi:10.1371/journal.pone.0017600.
147. Pigott, H. E., Leventhal, A. M., Alter, G. S., and Boren, J. J. (2010). Efficacy and effectiveness of antidepressants: current status of research. Psy-chother. Psychosom. 79, 267-279.
148. Pincus, H. A., Zarin, D. A., Tanielian, T. L., Johnson, J. L., West, J. C., Pettit, A. R., Pettit, A. R., Marcus, S. C., Kessler, R. C., and McIntyre, J. S. (1999). Psychiatric patients and treatments in 1997: findings from the American psychiatric practice research network. Arch. Gen. Psychi-atry 56, 441-449.
149. Popa, D., Cerdan, J., Reperant, C., Guiard, B. P., Guilloux, J. P., David, D. J., Gardier, A. M. (2010). A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. Eur. J. Pharmacol. 628, 83-90.
150. Post, A., Crochemore, C., Uhr, M., Holsboer, F., and Behl, C. (2000). Differential effects of antidepressants on the viability of clonal hippocampal cells. Biol. Psychiatry 47, 138.
151. Pozuelo, L., Zhang, J. P., Franco, K., Tesar, G., Penn, M., and Jiang, W. (2009). Depression and heart disease: what do we know, and where are we headed? Cleve. Clin. J. Med. 76, 59-70.
152. Ramaekers, J. G., Muntjewerff, N. D., and O'Hanlon, J. F. (1995). A comparative-study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br. J. Clin. Pharmacol. 39, 397-404.
153. Rantala, S., Vuopio-Varkila, J., Vuento, R., Huhtala, H., and Syrjanen, J. (2009). Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J. Infect. 58, 266-272.
154. Reeves, R. R., and Ladner, M. E. (2010). Antidepressant-induced suicidality: an update. CNS Neurosci. Ther. 16, 227-234.
155. Riedel, W. J., Eikmans, K., Heldens, A., and Schmitt, J. A. (2005). Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J. Psychopharmacol. 19, 12-20.
156. Romanovsky, A. A. (2007). Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R37-R46.
157. Romanovsky, A. A., Almeida, M. C., Aronoff, D. M., Ivanov, A. I., Konsman, J. P., Steiner, A. A., Turek, V. F. (2005). Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front. Biosci. 10, 2193-2216.
158. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeim, H. A., Kupfer, D. J., Luther, J., and Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905-1917.
159. Rutter, J. J., and Auerbach, S. B. (1993). Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265, 1319-1324.
160. Sairanen, M., Lucas, G., Ernfors, P., Castren, M., and Castren, E. (2005). Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 25, 1089-1094.
161. Sandercock, P. A. G., Counsell, C., and Kamal, A. K. (2008). Anticoagulants for acute ischaemic stroke. Cochrane Database Syst. Rev. 4, CD000024.
162. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., and Hen, R. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809.
163. Sapolsky, R. M. (2001). Depression, antidepressants, and the shrinking hippocampus. Proc. Natl. Acad. Sci. U.S.A. 98, 12320-12322.
164. Sapolsky, R. M. (2004). Why Zebras Don't Get Ulcers, 3rd Edn. New York, NY: Henry Holt and Company.
165. Sauer, W. H., Berlin, J. A., and Kimmel, S. E. (2003). Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108, 32-36.
166. Schlienger, R. G., Fischer, L. M., Jick, H., and Meier, C. R. (2004). Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf. 27, 1157-1165.
167. Schmaling, K. B., Dimidjian, S., Katon, W., and Sullivan, M. (2002). Response styles among patients with minor depression and dysthymia in primary care. J. Abnorm. Psychol. 111, 350-356.
168. Schmitt, J. A. J., Kruizinga, M. J., and Riedel, W. J. (2001). Nonserotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J. Psychopharmacol. 15, 173-179.
169. Schmitt, J. A. J., Ramaekers, J. G., Kruizinga, M. J., van Boxtel, M. P. J., Vuurman, E. F. P. M., and Riedel, W. J. (2002). Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J. Psychopharmacol. 16, 207-214.
170. Schulman, C. I., Namias, N., Doherty, J., Manning, R. J., Li, P., Elhaddad, A., Lasko, D., Amortegui, J., Dy, C. J., Dlugasch, L., Baracco, G., and Cohn, S. M. (2005). The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg. Infect. (Larchmt.) 6, 369-375.
171. Serretti, A., and Chiesa, A. (2009). Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J. Clin. Psychophar-macol. 29, 259-266.
172. Smoller, J. W., Allison, M., Cochrane, B. B., Curb, J. D., Perlis, R. H., Robinson, J. G., Rosal, M. C., Wenger, N. K., and Wassertheil-Smoller, S. (2009). Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch. Intern. Med. 169, 2128-2139.
173. Sonis, J. (2004). Mortality and poststroke depression. Am. J. Psychiatry 161, 1506-1507.
174. Stahl, S. (2008). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 3rd Edn. Cambridge: Cambridge University Press.
175. Stanley, E. D., Jackson, G. G., Panusarn, C., and Rubenis, M. (1975). Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231, 1248-1251.
176. Stergiou, L., and Hengartner, M. O. (2004). Death and more: DNA damage response pathways in the nematode C-elegans. Cell Death Dif-fer. 11, 21-28.
177. Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., and Rochester, G. (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339, b2880.
178. Swenson, B. R., Hedrick, T. L., Popovsky, K., Pruett, T. L., and Sawyer, R. G. (2007). Is fever protective in surgical patients with bloodstream infection? J. Am. Coll. Surg. 204, 815-821.
179. Tanrikut, C., Feldman, A. S., Altemus, M., Paduch, D. A., and Schlegel, P. N. (2010). Adverse effect of paroxetine on sperm. Fertil. Steril. 94, 1021-1026.
180. Tata, L. J., West, J., Smith, C., Farrington, P., Card, T., Smeeth, L., and Hubbard, R. (2005). General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91, 465-471.
181. Taupin, P. (2007). BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res. Rev. 53, 198-214.
182. Trifiro, G., Dieleman, J., Sen, E. F., Gambassi, G., and Sturkenboom, M. C. J. M. (2010). Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J. Clin. Psy-chopharmacol. 30, 252-258.
183. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., and Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 358, 252-260.
184. Ulak, G., Gocmez, S., Erden, F., Tanyeri, P., Utkan, T., Yildiz, F., Mutlu, O., and Gacar, N. (2006). Chronic administration of fluoxetine or venlafaxine induces memory deterioration in an inhibitory avoidance task in rats. Drug Dev. Res. 67, 456-461.
185. Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., and Beekman, A. (2007). Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry 22, 613-626.
186. van Haelst, I. M. M., Egberts, T. C. G., Doodeman, H. J., Traast, H. S., Burger, B. J., Kalkman, C. J., and van Klei, W. A. (2010). Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiol-ogy 112, 631-636.
187. Vickers, K. S., and Vogeltanz-Holm, N. D. (2003). The effects of rumination and distraction tasks on psychophysiological responses and mood in dysphoric and nondysphoric individuals. Cognit. Ther. Res. 27, 331-348.
188. Wakefield, J. C. (1992). The concept of mental disorder: on the boundary between biological facts and social values. Am. Psychol. 47, 373-388.
189. Wakefield, J. C. (1999). Evolutionary versus prototype analyses of the concept of disorder. J. Abnorm. Psychol. 108, 374-399.
190. Wakefield, J. C., Schmitz, M. F., and Baer, J. C. (2010). Does the DSM-IV clinical significance criterion for major depression reduce false positives? Evidence from the National Comorbidity Survey replication. Am.J.Psy-chiatry 167, 298-304.
191. Walker, A. J., Card, T., Bates, T. E., and Muir, K. (2011). Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br. J. Cancer 104, 193-197.
192. Warner-Schmidt, J. L., and Duman, R. S. (2006). Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16, 239-249.
193. Watson, P. J., and Andrews, P. W. (2002). Toward a revised evolutionary adaptationist analysis of depression: the social navigation hypothesis. J. Affect. Disord. 72, 1-14.
194. Weber, C. (2005). Platelets and chemokines in atherosclerosis: partners in crime. Circ. Res. 96, 612-616.
195. Weinstein, M. P., Iannini, P. B., Stratton, C. W., and Eickhoff, T. C. (1978). Spontaneous bacterial peritonitis: review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am.J.Med.64, 592-598.
196. Weinstein, M. P., Murphy, J. R., Reller, L. B., and Lichtenstein, K. A. (1983). The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. 2. Clinical observations, with special reference to factors influencing prognosis. Rev. Infect. Dis. 5, 54-70.
197. Wenzlaff, R. M., and Luxton, D. D. (2003). The role of thought suppression in depressive rumination. Cognit. Ther. Res. 27, 293-308.
198. Wilson, C. C., Faber, K. M., and Haring, J. H. (1998). Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: evidence for a glial mechanism. Brain Res. 782, 235-239.
199. Wingen, M., Bothmer, J., Langer, S., and Ramaekers, J. G. (2005). Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J. Clin. Psychiatry 66, 436-443.
200. Woods, A. H. (2009). "Evolution of homeostatic physiological systems," in Phenotypic Plasticity of Insects, eds D. Whitman and T. N. Ananthakrishnan (Plymouth: Science Publishers), 655-674.
201. Zimmerman, M., Galione, J. N., Attiullah, N., Friedman, M., Toba, C., Boerescu, D. A., and Ragheb, M. (2010). Underrecognition of clinically significant side effects in depressed outpatients. J. Clin. Psy-chiatry 71, 484-490.